𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remarkable effect of milnacipran in the treatment of Japanese major depressive patients

✍ Scribed by Hisashi Higuchi; Keizo Yoshida; Hitoshi Takahashi; Shingo Naito; Kei Tsukamoto; Mitsuhiro Kamata; Kenichi Ito; Kazuhiro Sato; Tetsuo Shimizu


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
35 KB
Volume
17
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The Place of Milnacipran in the Treatmen
✍ S. Kasper πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

Modern community-based studies have revealed high prevalence rates for major depression in adults. Despite this high prevalence, many depressed individuals do not seek treatment and only a minority of those that do are prescribed antidepressants. This paper considers the role of antidepressants, esp

Subjective and polysomnographic effects
✍ Patrick Lemoine; Thierry Faivre πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 62 KB

## Abstract The effects of milnacipran (50 mg bid) on sleep patterns of eight depressed inpatients, treated for 4 weeks, were studied during the initial (days 1–3) and terminal (days 26–28) treatment periods and compared with those obtained from three sleep recordings performed just prior to the in

Bupropion SR in the naturalistic treatme
✍ David C. Steffens; P. Murali Doraiswamy; Douglas R. McQuoid πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 1 views

## Abstract ## Introduction Bupropion immediate release (IR) and bupropion sustained release (SR) are frequently used to treat geriatric depression, as they have few cardiovascular, gastrointestinal and sexual adverse effects. We sought to examine the efficacy and dosing patterns of bupropion in a

Neuroendocrine and anthropometric measur
✍ Arun Ravindran; Robert Bialik; Pavel Hrdina; Zul Merali; Hymie Anisman; Yvon Lap πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

It has been suggested that weight change might be associated with certain neuroendocrine abnormalities often observed in patients suering from a depressive illness. This preliminary study examined whether objective measures of weight change were associated with dexamethasone suppression test (DST) r